Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $718.1550 (0.05%) ($718.1550 - $718.1550) on Mon. Jul. 3, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.7% (three month average) | RSI | 44 | Latest Price | $718.1550(0.05%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.8% a day on average for past five trading days. | Weekly Trend | REGN declines -3.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(47%) XLV(43%) DIA(30%) VYM(29%) XLF(28%) | Factors Impacting REGN price | REGN will decline at least -0.85% in a week (0% probabilities). VXX(-25%) VIXM(-20%) TBT(-3%) UUP(-0%) GLD(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.85% (StdDev 1.7%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $750.41 | 5 Day Moving Average | $711.01(1%) | 10 Day Moving Average | $743.98(-3.47%) | 20 Day Moving Average | $750.41(-4.3%) | To recent high | -13.5% | To recent low | 2.7% | Market Cap | $76.145b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |